MiniMed Flex™ Insulin Pump Now Accessible for Medicare Patients and Beneficiaries

MiniMed Flex™ Now Accessible to Medicare Beneficiaries

In a significant advancement for diabetes care, MiniMed (Nasdaq: MMED) has announced the availability of its innovative insulin pump system, the MiniMed Flex™, for Medicare and Medicare Advantage beneficiaries. This new offering has been designed to cater to individuals living with diabetes by providing a seamless and effective way to manage their condition.

Introduction of MiniMed Flex™

The MiniMed Flex™ is touted as the smallest app-controlled insulin pump system currently on the market. It measures about half the size of previous MiniMed pumps, being approximately the size of two stacked insulin vials while still accommodating 300 units of insulin. This compact design not only enhances comfort but also promotes ease of integration into daily life.

Utilizing SmartGuard™ technology, the same high-tech mechanism featured in the MiniMed™ 780G system, the MiniMed Flex™ automates insulin delivery adjustments every five minutes, around the clock.

Importance and Impact of Expanded Access

The expansion of MiniMed Flex™ access is particularly noteworthy given the positive outcomes previously observed among Medicare beneficiaries utilizing related technologies. Insights from real-world data presented at the 86th American Diabetes Association Scientific Sessions indicated that users of the MiniMed™ 780G system surpassed American Diabetes Association (ADA) glycemic targets, emphasizing the potential impact of this technology for a broader audience.

As Que Dallara, the CEO of MiniMed, stated, "Managing diabetes is relentless — and no one should have to do it without the best tools available. Ensuring Medicare access to MiniMed Flex™ is about making sure more people can benefit from technology that fits into daily life and takes some of the burden off their shoulders. Everyone deserves that regardless of age."

Charlie Saxe, a user of the MiniMed Flex™, expressed his satisfaction, stating, "The biggest difference with MiniMed Flex is that diabetes doesn't demand my attention as often. The pump stays tucked away, and I manage everything through the app. It gives me more confidence and lets me focus on my life instead of constantly thinking about my diabetes."

Product Availability

In the U.S. market, the MiniMed Flex™ is initially available with the Simplera Sync™ sensor and will soon be offered with the Instinct sensor by Abbott later this summer. This variety allows users to select a sensor that best suits their personal needs and lifestyle.

Conclusion and Future Outlook

As MiniMed continues to lead in the field of diabetes management technology, the emergence of the Flex™ system marks a transformative step towards making diabetes care more accessible and manageable for Medicare beneficiaries. With over 40 years of experience in insulin delivery, MiniMed remains dedicated to innovating and easing the daily burdens faced by those living with diabetes.

For more information about the MiniMed Flex™ system, including details on ordering and reimbursement support, you can visit www.minimed.com/flex.

About MiniMed

MiniMed stands as a trailblazer in insulin delivery systems and diabetes technology, actively operating in 80 countries and pushing the boundaries of innovation to enhance the quality of life for people with diabetes. Their comprehensive ecosystem includes an array of insulin delivery systems, continuous glucose monitors (CGMs), advanced algorithms, and user-friendly app experiences that seamlessly integrate for optimal diabetes management.

Please be aware that expectations regarding future developments are subject to risks and uncertainties. The actual results may differ substantially from those anticipated due to various factors, which are detailed in MiniMed's reports filed with the Securities and Exchange Commission.